ストックスクリーナーアプリを入手
16.91
0.06%
-0.01
アフターアワーズ：
16.58
-0.33
-1.95%
Maplight Therapeutics Inc (MPLT) 最新ニュース
Long term debt to total assets ratio of MapLight Therapeutics, Inc. – BOATS:MPLT - TradingView
MapLight Therapeutics, Inc. Cash Flow – BOATS:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) options chain - Yahoo! Finance UK
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN
MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada
Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights
MapLight Therapeutics Closes Successful IPO and Private Placement - MSN
Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks
Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals
MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com
Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks
MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada
MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Total equity of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total liabilities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted earnings per share (diluted EPS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Revenue Breakdown – NASDAQ:MPLT - TradingView
Total liabilities & shareholders' equities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted net income available to common stockholders of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Net debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Inventory turnover of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Operating expenses (excl. COGS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Taxes of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Financial Statements – NASDAQ:MPLT - TradingView
Total revenue of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Total operating expenses of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Gross profit of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Net income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Cost of goods sold of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Non-operating income (total) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Pretax income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
After tax other income/expense of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Diluted shares outstanding of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Earnings and Revenue – NASDAQ:MPLT - TradingView
Dilution adjustment of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Price to cash flow ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
EBITDA margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Balance Sheet – NASDAQ:MPLT - TradingView
Non-controlling/minority interest of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Quick ratio of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
Muscarinic path still charting as Maplight IPO gets $258M - BioWorld MedTech
MapLight Therapeutics, Inc. Income Statement – NASDAQ:MPLT - TradingView
Net margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. Statistics – NASDAQ:MPLT - TradingView
MapLight Therapeutics, Inc. (MPLT) Valuation Measures & Financial Statistics - Yahoo! Finance Canada
MapLight Therapeutics, Inc. (MPLT) Company Profile & Facts - Yahoo! Finance Canada
MPLT: Static price chart | MapLight Therapeutics, Inc. | US56565P1030 - MarketScreener
MapLight Therapeutics announces pricing of IPO - The Pharma Letter
Sergey Brin nonprofit gets $261 million lift in MapLight IPO - Crain Currency
MapLight shares track up after $251m IPO - pharmaphorum
MapLight Therapeutics, Inc. (MPLT) Options Chain - Yahoo! Finance Canada
Latham & Watkins Advises on MapLight Therapeutics’ Initial Public Offering - Legal Desire Media and Insights
MapLight Therapeutics, Inc.(NasdaqGS: MPLT) added to NASDAQ Composite Index - MarketScreener
MapLight Therapeutics Inc. (MPLT): Oversubscribed Neuroscience IPO Launches with a Bright Start - Smartkarma
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO (2) - Bloomberg Law News
Biotech MapLight Jumps 8% in First US IPO Using Shutdown Fix - Bloomberg
Biotech Firm MapLight Inks $251M IPO Amid Shutdown - Law360
MapLight Therapeutics raises $258M in IPO, private placement - Axios
CNS drug developer MapLight goes public, stock up 9% on first day of trading - The Business Journals
Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut - Yahoo Finance
MapLight Therapeutics debuts on Nasdaq at $19, above $17 IPO price - Investing.com Canada
MapLight Therapeutics valued at $787 million as shares jump in Nasdaq debut - TradingView
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):